Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

The mortality rate of non-small-cell lung cancer (NSCLC) remains high worldwide. Although cisplatin-based chemotherapy may greatly enhance patient prognosis, chemotherapy resistance remains an obstacle to curing patients with NSCLC. Therefore, overcoming drug resistance is the main route to successf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cell Dev Biol
Main Authors: Wu, Li-Mei, Liao, Xiao-Zhong, Zhang, Yan, He, Zi-Rui, Nie, Shi-Qing, Ke, Bin, Shi, Lin, Zhao, Jian-Fu, Chen, Wen-Hui
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Cell and Developmental Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7892899/
https://ncbi.nlm.nih.gov/pubmed/33614623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.610097
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados